D-4 DOPAMINE-RECEPTOR BINDING-AFFINITY DOES NOT DISTINGUISH BETWEEN TYPICAL AND ATYPICAL ANTIPSYCHOTIC-DRUGS

被引:136
作者
ROTH, BL
TANDRA, S
BURGESS, LH
SIBLEY, DR
MELTZER, HY
机构
[1] CASE WESTERN RESERVE UNIV,SCH MED,DEPT PSYCHIAT,CLEVELAND,OH 44106
[2] NINCDS,EXPTL THERAPEUT BRANCH,MOLEC NEUROPHARMACOL SECT,BETHESDA,MD 20892
关键词
ANTIPSYCHOTIC DRUGS; D-4 DOPAMINE RECEPTOR; RAT;
D O I
10.1007/BF02311185
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The affinities of 13 atypical and 12 typical antipsychotic drugs for the cloned rat D-4 dopamine receptor and the D-4/D-2 ratios were examined. Of the atypical antipsychotic drugs tested, only clozapine, risperidone, olanzapine, zotepine and tiospirone had affinities less than 20 nM. In fact, many atypical antipsychotic drugs had relatively low affinities for the cloned rat D-4 receptor, with Ki values greater than 100 nM (Seroquel, fluperlapine, tenilapine, FG5803 and melperone). Additionally, several typical antipsychotic drugs had high affinities for the cloned rat D-4 receptor, with K(i)s less than 20 nM (loxapine, chlorpromazine, fluphenazine, mesoridazine, thioridazine and trifluoroperazine). The ratios of D-2/D-4 affinities did not differentiate between these two types of antipsychotic drugs. Thus, D-4 dopamine receptor affinity, used as a single measure, does not distinguish between the group of typical and atypical antipsychotic drugs analyzed.
引用
收藏
页码:365 / 368
页数:4
相关论文
共 21 条
[1]  
ALTAR CA, 1988, N-S ARCH PHARMACOL, V338, P162
[2]  
ANDERSEN PH, 1986, J NEUROCHEM, V47, P1830
[3]  
ASHGARI V, 1994, MOL PHARM, V46, P364
[4]  
BEASLEY CM, 1995, IN PRESS NEUROPSYCHO
[5]  
BOLDEN C, 1992, J PHARMACOL EXP THER, V260, P576
[6]  
Burgess Loyd H., 1994, Society for Neuroscience Abstracts, V20, P525
[7]   INVIVO POTENCIES OF ANTIPSYCHOTIC-DRUGS IN BLOCKING ALPHA-1 NORADRENERGIC AND DOPAMINE D2 RECEPTORS - IMPLICATIONS FOR DRUG MECHANISMS OF ACTION [J].
COHEN, BM ;
LIPINSKI, JF .
LIFE SCIENCES, 1986, 39 (26) :2571-2580
[8]  
KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789
[9]   DOPAMINE-D(4) VERSUS DOPAMINE D(2) RECEPTOR SELECTIVITY OF DOPAMINE RECEPTOR ANTAGONISTS - POSSIBLE THERAPEUTIC IMPLICATIONS [J].
LAHTI, RA ;
EVANS, DL ;
STRATMAN, NC ;
FIGUR, LM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 236 (03) :483-486
[10]  
MELTZER HY, 1979, AM J PSYCHIAT, V136, P1550